SHOULDER INNOVATIONS, INC. (SI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $21.00K; Additional Paid in CapitalUSD $240.34M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $21.00K; Additional Paid in CapitalUSD $238.84M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-64.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $21.00K; Additional Paid in CapitalUSD $238.01M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $117.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $21.00K; Additional Paid in CapitalUSD $237.40M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $39.00K.
SHOULDER INNOVATIONS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $21.00K | $240.34M | $-104.00K | $-115.93M | $124.33M | 3 month · $1.08M |
| 2026-03-31 | $0.00 | $21.00K | $238.84M | $-64.00K | $-105.78M | $133.02M | 3 month · $726.00K |
| 2025-12-31 | $0.00 | $21.00K | $238.01M | $117.00K | $-97.40M | $140.75M | 12 month · $996.00K |
| 2025-09-30 | $0.00 | $21.00K | $237.40M | $39.00K | $-89.63M | $147.83M | 3 month · $298.00K |
| 2025-06-30 | (m) | $1.00K | $2.62M | $82.00K | $-80.90M | $-78.20M | 3 month · $190.00K |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $-59.31M | 3 month · $127.00K |
| 2024-12-31 | $0.00 | $1.00K | $2.15M | $197.00K | $-57.04M | $-54.70M | 12 month · $754.00K |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | $-50.88M | 3 month · $237.00K |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | $-47.19M | 3 month · $170.00K |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | $-43.13M | 3 month · $168.00K |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $-39.74M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |